In the last of her five-part series, contributor Lori Weiman takes a deep dive into FDA guidelines and explains how pharmaceutical advertisers and their partners can avoid costly violations.
from
http://marketingland.com/manage-ad-partners-regulated-industries-pharma-part-5-5-189439
No comments:
Post a Comment